Clinical Trials Logo

Autism clinical trials

View clinical trials related to Autism.

Filter by:

NCT ID: NCT02069977 Recruiting - Autism Clinical Trials

Study to Evaluate the Efficacy and Safety of Aripiprazole

Start date: February 2014
Phase: Phase 4
Study type: Interventional

- To evaluate the efficacy of flexibly dosed aripiprazole in reducing serious behavioral problems in Asian children and adolescents with a diagnosis of autism spectrum disorder, as measured by change from baseline to endpoint on the irritability subscale of the aberrant behavior checklist (ABC-I). - To evaluate the long-term safety and tolerability of flexibly dosed aripiprazole in the treatment of serious behavioral problems in Asian children and adolescents with a diagnosis of autism spectrum disorder.

NCT ID: NCT02059577 Completed - Autism Clinical Trials

Nutritional and Dietary Treatment Study for Children/Adults With Autism

Start date: November 2011
Phase: Phase 2
Study type: Interventional

70 children and adults with autism spectrum disorders will be enrolled in a 1-year, single-blind treatment study. Assessments will be conducted at the beginning and end of the study, including measurements of nutritional, metabolic, and digestive status and assessments of autism severity and overall functioning. Half of the participants will be randomized into a treatment study, and half will be randomized to no changes in their current treatments. Treatments will be added in a sequential manner over 12 months, including vitamin/minerals, essential fatty acids, carnitine, digestive enzymes, and healthy, gluten-free, casein-free diets. A dedicated team of nutritionists, nurses, and physicians will support and monitor the participants throughout the study. A group of 50 neurotypical children and adults, of similar age and gender, will be included for comparison.

NCT ID: NCT02037022 Completed - Autism Clinical Trials

Pivotal Response Treatment Package for Young Children With Autism

PRT-P
Start date: December 4, 2013
Phase: N/A
Study type: Interventional

This is a research study examining the effectiveness of a pivotal response treatment package (PRT-P) in targeting language skills in young children with autism.

NCT ID: NCT02028247 Completed - Autism Clinical Trials

Psychotherapy for Anxiety in Children With Autism Spectrum Disorder

TAASD
Start date: April 2014
Phase: N/A
Study type: Interventional

Anxiety disorders affect 40 to 50% of children with autism spectrum disorders (ASD), contributing to substantial distress and impairment. The goal of this study is to examine the effectiveness of a personalized type of psychotherapy against standard-care psychotherapy for addressing anxiety in youth with ASD.

NCT ID: NCT02004236 Completed - Autism Clinical Trials

Transcranial Random Noise Stimulation (tRNS) Over Fronto-temporal Cortex Improves Verbal Fluency and Empathy in Autism Children

tRNS25112013
Start date: January 2014
Phase: N/A
Study type: Interventional

Interventional, prospective, randomized, double-blind, placebo-controlled and parallel assignment study, in which patients with Autism Spectrum Disorder (ASD) are two types of intervention by transcranial random noise stimulation (tRNS), to improve verbal fluency and empathy.

NCT ID: NCT02000284 Active, not recruiting - Clinical trials for Autism Spectrum Disorder

Mitochondrial Dysfunction in Autism Spectrum Disorder

Mito
Start date: October 16, 2012
Phase:
Study type: Observational

Researchers at Arkansas Children's Hospital Research Institute are conducting a study about mitochondrial function in children. The study involves up to 5 visits to Arkansas Children's Hospital with fasting blood draws, behavioral assessments, and/or questionnaires. This study is not currently recruiting, but continues to follow those who were enrolled. There is no cost for visits or study-related exams. For further information, please contact the program manager, Leanna Delhey, at ldelhey@uams.edu or 501-364-4519

NCT ID: NCT01999894 Completed - Autism Clinical Trials

Open-label Study of Safety and Tolerability of Memantine in Children With Autism

Start date: November 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the long-term safety and tolerability of memantine in the treatment of autism in pediatric patients.

NCT ID: NCT01996800 Terminated - Autism Clinical Trials

Study of Chiropractic and Neuromuscular Reeducation as a Treatment for Autism Symptoms

Start date: August 2013
Phase: Phase 1
Study type: Interventional

This study explores the effectiveness of chiropractic and neuromuscular reeducation as complementary and alternative medicine treatment approaches for autism. Our investigation maintains the following three hypotheses: 1. Spinal manipulative therapy (SMT) will reduce the presentation of autistic symptoms in children. 2. Spinal manipulative therapy (SMT) in conjunction with neuromuscular reeducation will reduce the presentation of autistic symptoms in children. 3. The presentation of autistic symptoms in children will significantly differ between the treatment groups of spinal manipulative therapy and spinal manipulative therapy in unification with neuromuscular reeducation.

NCT ID: NCT01983189 Terminated - Autism Clinical Trials

Transcranial Magnetic Stimulation for Evaluation and Treatment of Repetetive Behaviors in Autism

Start date: November 2008
Phase: Phase 2
Study type: Interventional

This study is a trial of low frequency Repetitive Transcranial magnetic stimulation( rTMS) for subjects with autism spectrum disorders, specially targeting repetitive behaviors.

NCT ID: NCT01980186 Enrolling by invitation - Autism Clinical Trials

Transcranial Ultrasonography Using Linear 2D Imaging of the Brain

Start date: November 2013
Phase: N/A
Study type: Observational

This study will use linear 2D ultrasound imaging to look at the brain of individuals diagnosed with autism and their siblings. This is called transcranial ultrasound (TUS). It is hypothesized that TUS will allow real-time imaging of the fluid spaces outside the brain and will further allow the imagining of brain areas important to language and social function.